The Pennant Group Inc. (PNTG)
NASDAQ: PNTGHealth CareMedical/Nursing ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PNTG stock chart
Technical analysisKey statistics
All statistics- Market cap
- $1.22B
- P/E (TTM)
- 34.30
- Forward P/E
- 22.00
- EPS (TTM)
- $1.01
- Dividend yield
- None
- 52-week range
- 26.40 – 44.24
- Day range
- 34.06 – 34.97
- Volume / Avg
- 444.53K / 391.52K
- Beta
- —
- Shares outstanding
- 35.13M
52-week range
PNTG stock today
Shares of Pennant Group (PNTG) finished higher on Nov 20 at $34.64, a gain of 1.61% or $0.55 per share, versus the S&P 500's 3.70% decline. Shares are 21.7% below their 52-week high of $44.24, set on Nov 4, 2026 and 31.2% above the 52-week low of $26.40, in the middle of the past year's range. PNTG is up 23.1% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 29.9%.
At 34.3x trailing earnings, Pennant Group trades above the peer-group median of 29.7x. Its forward P/E of 22.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Pennant Group
Company profileThe Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services.
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- CEO
- Mr. Brent J. Guerisoli
- Headquarters
- Eagle, ID
- Employees
- 9,700
- Website
- pennantgroup.com
Financial highlights
Full financialsIn fiscal 2025, Pennant Group generated $947.7 million in revenue, up 36.3% from fiscal 2024, its 8th consecutive year of revenue growth. Net income was $29.6 million (+31.1% year over year), for a net margin of 3.1% versus a median of 2.5% in the prior 5 years. Gross margin was 18.9% (down from 19.7%) and operating margin 5.5%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $947.71M | $695.24M | $544.89M | $473.24M | $439.69M |
| Growth | +36.31% | +27.59% | +15.14% | +7.63% | +12.47% |
| Net income | $29.58M | $22.56M | $13.38M | $6.64M | $2.70M |
| EPS (diluted) | $0.84 | $0.70 | $0.44 | $0.22 | $0.09 |
Analyst forecast
ForecastConsensus (7 analysts)
strong_buy
Avg. price target
$48.00+38.57%
- Strong buy 1
- Buy 6
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 4, 2026
- EPS actual vs est.
- $0.26 vs $0.28
- Surprise
- -7.14%
PNTG news
All PNTG news- Pennant Group to Participate in the 2026 Stephens Annual Investment ConferenceGlobeNewswire
- Pennant: 3 Key Takeaways for Long-Term InvestorsNasdaq
- Pennant Group (PNTG) Q3 2026 Earnings Call TranscriptNasdaq
- Pennant Reports Third Quarter 2026 ResultsGlobeNewswire
- Pennant Announces Third Quarter 2026 Earnings Release and CallGlobeNewswire
- Can Ensign Group's Operating Model Drive Growth Beyond Acquisitions?NasdaqENSG, BKD, PNTG
- Here's Why Ensign Group Stock Remains a Buy for InvestorsNasdaqENSG, THC, PNTG, PACS
Pennant Group peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| INNVInnovAge Holding Corp. | 9.16 | +2.81% | $1.25B | vs PNTG |
| TDOCTeladoc Health Inc. | 7.45 | -4.36% | $1.36B | vs PNTG |
| WGSGeneDx Holdings Corp. Class A | 45.46 | -7.68% | $1.36B | vs PNTG |
| AHCOAdaptHealth Corp. | 7.20 | -0.69% | $982.98M | vs PNTG |
| USPHU.S. Physical Therapy Inc. | 95.93 | +1.71% | $1.43B | vs PNTG |
| OMDAOmada Health Inc. | 11.87 | -5.04% | $736.39M | vs PNTG |
| SBCSBC Medical Group Holdings Incorporated | 5.17 | -7.68% | $530.32M | vs PNTG |
| SRTAStrata Critical Medical Inc. Class A | 4.56 | -5.59% | $407.30M | vs PNTG |
Indexes, lists and sector
Pennant Group stock FAQ
What is Pennant Group's stock price today?
PNTG last traded at $34.64 as of Nov 20, 4:00 PM EST, up 1.61% on the day. Prices are delayed at least 15 minutes.
What is PNTG's P/E ratio?
PNTG trades at a trailing P/E ratio of 34.30 and a forward P/E of 22.00, compared with a median of 29.7 for its closest peers.
Who is Pennant Group's CEO?
Mr. Brent J. Guerisoli is the chief executive officer of The Pennant Group Inc., which has about 9,700 employees.
What is the PNTG 52-week high?
The 52-week high for PNTG is $44.24 and the 52-week low is $26.40. The stock is currently 21.7% below its high.